Attention-deficit/Hyperactivity Disorder in the context of Autism spectrum disorders.

作者: Michael J. Murray

DOI: 10.1007/S11920-010-0145-3

关键词:

摘要: Autism spectrum disorders (ASD) are frequently marked by symptoms consistent with attention-deficit/hyperactivity disorder (ADHD), namely inattention, hyperactivity, and impulsivity. Recent work has established that about half of the ASD population also meets diagnostic criteria for ADHD, although comorbid diagnoses precluded DSM-IV-TR. Individuals co-occurring ADHD more severely impaired, significant deficits seen in social processing, adaptive functioning, executive control. Children prone to motor problems, which lead especially poor outcomes. demonstrated high rates a subset children ADHD. Medication studies have efficacy methylphenidate, atomoxetine, guanfacine, among others, treating ASD. However, these effects were not as great those when primary they less well-tolerated population.

参考文章(48)
Benjamin L. Handen, Cynthia R. Johnson, Martin Lubetsky, Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder. Journal of Autism and Developmental Disorders. ,vol. 30, pp. 245- 255 ,(2000) , 10.1023/A:1005548619694
Robert L. Findling, Nora K. McNamara, Barbara L. Gracious, Mary Ann O'Riordan, Michael D. Reed, Christine Demeter, Jeffrey L. Blumer, Quetiapine in nine youths with autistic disorder. Journal of Child and Adolescent Psychopharmacology. ,vol. 14, pp. 287- 294 ,(2004) , 10.1089/1044546041649129
James T. McCracken, James McGough, Bhavik Shah, Pegeen Cronin, Daniel Hong, Michael G. Aman, L. Eugene Arnold, Ronald Lindsay, Patricia Nash, Jill Hollway, Christopher J. McDougle, David Posey, Naomi Swiezy, Arlene Kohn, Lawrence Scahill, Andres Martin, Kathleen Koenig, Fred Volkmar, Deirdre Carroll, Allison Lancor, Elaine Tierney, Jaswinder Ghuman, Nilda M. Gonzalez, Marco Grados, Benedetto Vitiello, Louise Ritz, Mark Davies, James Robinson, Don McMahon, Risperidone in Children with Autism and Serious Behavioral Problems The New England Journal of Medicine. ,vol. 347, pp. 314- 321 ,(2002) , 10.1056/NEJMOA013171
Sam Goldstein, Adam J. Schwebach, The Comorbidity of Pervasive Developmental Disorder and Attention Deficit Hyperactivity Disorder: Results of a Retrospective Chart Review Journal of Autism and Developmental Disorders. ,vol. 34, pp. 329- 339 ,(2004) , 10.1023/B:JADD.0000029554.46570.68
Kimberly A. Stigler, Lael A. Desmond, David J. Posey, Ryan E. Wiegand, Christopher J. McDougle, A naturalistic retrospective analysis of psychostimulants in pervasive developmental disorders. Journal of Child and Adolescent Psychopharmacology. ,vol. 14, pp. 49- 56 ,(2004) , 10.1089/104454604773840481
J. Helen Yoo, Maria G. Valdovinos, Dean C. Williams, Relevance of donepezil in enhancing learning and memory in special populations: a review of the literature Journal of Autism and Developmental Disorders. ,vol. 37, pp. 1883- 1901 ,(2007) , 10.1007/S10803-006-0322-8
Robert A Avery, Jenna S Franowicz, Colin Studholme, Christopher H van Dyck, Amy FT Arnsten, The Alpha-2A-Adrenoceptor Agonist, Guanfacine, Increases Regional Cerebral Blood Flow in Dorsolateral Prefrontal Cortex of Monkeys Performing a Spatial Working Memory Task Neuropsychopharmacology. ,vol. 23, pp. 240- 249 ,(2000) , 10.1016/S0893-133X(00)00111-1
David J. Posey, Ryan E. Wiegand, Jennifer Wilkerson, Melissa Maynard, Kimberly A. Stigler, Christopher J. McDougle, Open-label atomoxetine for attention-deficit/ hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders. Journal of Child and Adolescent Psychopharmacology. ,vol. 16, pp. 599- 610 ,(2006) , 10.1089/CAP.2006.16.599
Ami Klin, Celine A. Saulnier, Sara S. Sparrow, Domenic V. Cicchetti, Fred R. Volkmar, Catherine Lord, Social and communication abilities and disabilities in higher functioning individuals with autism spectrum disorders: the Vineland and the ADOS. Journal of Autism and Developmental Disorders. ,vol. 37, pp. 748- 759 ,(2007) , 10.1007/S10803-006-0229-4